Richard S. Warzala - 05 Mar 2026 Form 4 Insider Report for ALLIENT INC (ALNT)

Role: Chief Executive Officer, Director
Signature: /s/ Michael C. Donlon, Attorney-in-Fact for Richard S. Warzala
Issuer symbol: ALNT
Transactions as of: 05 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 09 Mar 2026, 19:59:27 UTC
Previous filing: 02 Jan 2026
Next filing: 03 Apr 2026
SEC: View on sec.gov

Quoteable Key Fact

"Richard S. Warzala filed Form 4 for ALLIENT INC (ALNT) on 09 Mar 2026."

Quick Takeaways

This page summarizes Richard S. Warzala's Form 4 filing for ALLIENT INC (ALNT).
3 reported transactions and 0 derivative rows are listed below.
Filing timestamp: 09 Mar 2026, 19:59.

What Changed

Previous filing in this sequence was filed on 02 Jan 2026.
Current net transaction value: $0.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
WARZALA RICHARD S	Chief Executive Officer, Director	ALLIENT INC., 495 COMMERCE DRIVE, AMHERST	/s/ Michael C. Donlon, Attorney-in-Fact for Richard S. Warzala	09 Mar 2026	0001024225

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALNT	Common Stock	Award		+18,850	+1.2%	$62.07^*	1,572,736	05 Mar 2026	Direct	F1
transaction	ALNT	Common Stock	Award		+15,709	+1%	$62.07^*	1,588,445	05 Mar 2026	Direct	F2
transaction	ALNT	Common Stock	Award		+3,617	+0.23%	$62.07^*	1,592,062	05 Mar 2026	Direct	F3
holding	ALNT	Common Stock						26,067	05 Mar 2026	By ESOP Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of time-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares vest one-third each on April 1, 2027, 2028 and 2029.
F2	Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. All or a portion of these restricted shares will vest over a three-year period upon the satisfaction of certain performance goals established by the Compensation Committee for the year ending December 31, 2026.
F3	Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares were earned upon the satisfaction of certain performance goals established by the Compensation Committee for the year ended December 31, 2025 and vest one-third each on April 1, 2026, 2027 and 2028.